Here are six key notes:
1. The institute has been selected as a clinical site for trials conducted by both Spinal Kinetics and Titan Spine.
2. Patients will be enrolled in the respective clinical trials at Laser Spine Institute’s ASC in Tampa, Fla.
3. Spinal Kinetics’ FDA-regulated clinical trial is studying the M6-C artificial cervical disc, a motion preservation technology. Laser Spine Institute will enroll patients in the anterior cervical discectomy and fusion control group arm of the trial.
4. Titan Spine’s clinical trials will involve transforaminal lumbar interbody fusion procedures for up to 25 trial patients. The procedure fuses the anterior and posterior columns of the spine through a posterior approach.
5. This announcement comes just one month after Laser Spine Institute named neurosurgeon Reginald J. Davis, MD, its inaugural director of clinical research.
6. Dr. Davis’ role is to facilitate research efforts and develop collaborative partnerships.
More articles on ASC issues:
18 statistics on ASC case volume
If healthcare providers don’t adopt digital technology, quality suffers — 7 survey highlights
10 statistics on clinical & office staff additions in the coming year
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.